Periodic monitoring Active

Key facts

  • In August 2025, 96 measles cases were reported by nine countries in the EU/EEA. Eighteen countries reported zero cases.
  • During the 12-month period, eight deaths attributable to measles were reported to ECDC by Romania (five), France (two) and the Netherlands (one) 
  • Overall, case numbers decreased compared with the previous month; this is consistent with the seasonality of measles.
  • Outbreaks have been detected through supplementary epidemic intelligence activities in the EU/EEA (Spain, France) and other countries.

Overview

Since March 2025, an overall decrease in reported cases has been observed. A further decline in case numbers was expected over the summer months, in line with the known seasonality of measles.

In August 2025, 27 countries reported measles data, with 96 cases reported by nine countries. There were 18 countries that reported zero cases.

Overall, case numbers decreased compared with the previous month, however this may be subject to change in the event of a future retrospective update. The highest case counts were reported by Romania (30), France (27), Poland (11) and Spain (nine).

Between 1 September 2024 to 31 August 2025, 30 EU/EEA Member States reported a total of 10 825 cases of measles,  7 738 (71.5%) of which were laboratory confirmed. Of the 10 825 cases with known age, 4 448 (41.1%) were in children aged under five years; and 3 461 (32.0%) cases were aged 15 years or above. The highest notification rates were observed in infants under one year of age (364.4 cases per million) and children aged 1-4 years (187.8 cases per million).

Of 10 129 cases (93.6% of all cases) with a known age and vaccination status, 8 403 (83.0%) were unvaccinated, 918 (9.1%) were vaccinated with one dose of a measles-containing vaccine, 676 (6.7%) were vaccinated with two or more doses, and 113 (1.1%) were vaccinated with an unknown number of doses.

During the 12-month period, eight deaths (case fatality rate (CFR): 0.074%) attributable to measles were reported to ECDC by Romania (five), France (two) and Netherlands (one). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.

Complementary epidemic intelligence surveillance has been conducted, with data collection between 8 and 9 September 2025. No large outbreaks have been detected, overall a decline in measles cases has been observed.

Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to EpiPulse Cases. Data presented in the two monthly reports may differ.

Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:

Austria has reported 149 measles cases in 2025 and as of 1 October 2025, an increase by five cases since 3 September 2025. The recent cases were reported in weeks 37 and 39 in Lower Austria and in Tirol.

Belgium: there have been no measles outbreaks reported in Belgium. In August 2025, Belgian authorities have begun a SEROPREV project aiming at establishing a national serum bank and measure seroprevalence of measles and other infections in Belgium.

Germany reported 237 confirmed and probable measles cases in 2025 and as of 7 October 2025 an increase of 20 cases since 8 September 2025. No outbreaks have been detected by ECDC EI group.

Italy reported a decrease in the reported cases of measles in July and August 2025. Overall, 432 cases were reported in Italy in 2025 and as of 31 August. Twenty regions reported measles, with the majority of the cases (64%) reported in Lombardy, Emilia Romagna, Lazio, Calabria and Sicily. Almost half of the cases (49%) are 15 years of age or older (median 31 years of age), however highest incidence is seen in children under five years of age. Vast majority of the cases are unvaccinated (87% of the 94.4% with known vaccination status). About a third of the cases reported at least one complication, of which the most frequent were hepatitis/increased of transaminases and pneumonia; three patients developed encephalitis.

Lithuania reported 9 cases in 2025 as of 7 October 2025, an increase of one case since 5 September 2025.

The Netherlands reported 506 cases of measles as of 10 September 2025, seven more cases since 13 August 2025. The recent cases are family related and individual cases. There is no indication of a national outbreak. In 2025, 59 cases were reported to have contracted measles abroad (four new cases reported in the past month), with most of these infections occurring in Morocco (39). Other cases had travel histories to Greece, Romania, Vietnam, Türkiye, Belgium, Uganda, Iran, Bosnia and Herzegovina, China, Malaysia, and France.

Norway reported four cases of measles in 2025 and as of 7 October, an increase by one case since 15 April 2025.

Poland reported 75 measles cases in 2025 and as of 30 September, an increase of four cases since 31 August 2025.

Romania reported 8 369 measles cases and eight deaths in 2025 and as of 30 September 2025, an increase of 49 cases since 31 August 2025. No new deaths were reported in this reporting period. A decreasing trend is observed in 2025, with fewer cases reported per month compared to the same period in 2024.

Spain reported 344 cases as of 30 September 2025 an increase of

14 cases since (increase by 14 cases since 31 August 2025), of which 100 were

imported and 91 were related to imported cases.

An ongoing outbreak has been reported in Garraf, Catalonia by the Public Health Agency of Catalonia. Eight confirmed measles cases are epidemiologically linked (family contact, care centres, various community, leisure and university

environments). The first patient developed symptoms on 4 September 2025 and the most recent case had onset of symptoms on 29 September 2025. Most of the cases are in adolescents and young adults; six individuals were not vaccinated, and three

people required hospitalisation. Around a hundred people have been identified through contact tracing who are being followed up by local health authorities. The risk of infection transmission in the affected area is considered high, as most of the affected people are not immunised, and have high mobility and social interaction.

Sweden reported eight measles cases in 2025 and as of 8 October, an increase of one case since 8 July 2025.

Epidemiological summary for EU/EEA outermost territories with relevant epidemic intelligence updates:

The Réunion Regional Health Agency reported four locally acquired measles cases between July and October 2025 (report on 3 October 2025). Two were children under the age of five years (one of them not eligible for vaccination) and two adults. The recent case was reported in week 40 (ending on 5 October 2025). The previous outbreak of measles in Reunion was in 2019 and affected 96 people. According to the vaccination bulletin published by Public Health France in April 2025, the two-dose vaccination coverage (VC) for infants against Measles, Mumps, and Rubella (MMR) was 80% in 2024.

Epidemiological summary for select countries outside of the EU/EEA with relevant epidemic intelligence updates:

England reported 772 laboratory confirmed measles cases, including one death, from January to 25 September 2025. A downward trend is observed since mid-July, after the outbreak started in April 2025. The most affected regions were London and the Northwest regions.

Ukraine reported 1 425 measles cases from January to August 2025.

According to the report by Africa CDC published on 30 September 2025, a total of 126 503 measles cases (9 537 confirmed) and 9 956 deaths (CFR: 0.76%) have been reported from 20 countries: Cameroon, Chad, Democratic Republic of the Congo, Ethiopia, Guinea, Kenya, Malawi, Mali, Mauritania, Morocco, Mozambique, Namibia, Nigeria, Rwanda, Senegal, Somalia, South Africa, Sudan, Uganda, Zambia.

According to the WHO Pan American Health Organization (WHO PAHO) report published on 26 September 2025, 11 668 confirmed cases were reported by ten countries, the majority of which have been reported by Canada (5 006), Mexico (4 645), and the United States (US) (1 509).

Canada reports an ongoing multijurisdictional outbreak of measles affecting 10 jurisdictions. Most of the reported cases are linked to this outbreak (4 960 cases, of which 4 566 confirmed, 394 probable). One death with congenital measles has been reported in relation to this outbreak. the most recent cases had onset of symptoms on week 39 (21 to 27 September 2025).

As of 8 October 2025, the US has reported1 563 confirmed measles cases in 2025, including three deaths in 42 jurisdictions. Ninety-two percent of the cases were unvaccinated or had an unknown vaccination status. Eighty-seven percent of the cases were related to 44 outbreaks.

As of report on 7 October 2025, Mexico has reported 4 857 confirmed cases, including 22 deaths in weeks 1–41 of 2025. Most of the cases are reported in the region Chihuahua (4 368 cases, including 21 deaths).

According to a WHO Western Pacific Region (WHO WPRO) report for January to September 2025, there were 14 364 confirmed measles reported in the region in 14 countries. Most of the cases have been reported in Indonesia (6 748), Mongolia (1 595), Laos (1 470), China (1 429), Cambodia (1 098), and the Philippines (1 011), followed by Malaysia (443), Japan (222), Vietnam (144), Australia

For more information on the provisional number of cases outside the EU/EEA region, please visit the WHO website.

The numbers provided to WHO for EU/EEA countries are from EpiPulse Cases data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.

ECDC assessment

Although most recent cases were acquired through local or community transmission, travel-related cases continue to be reported.

Continued vigilance is essential due to suboptimal vaccination coverage for measles-containing vaccines (MCV) in several EU/EEA countries, the possible introduction from areas with ongoing transmission, and increased travel and population movement during the holiday period.

Actions

ECDC is monitoring the measles situation through its epidemic intelligence activities. Data collected via epidemic intelligence supplement the monthly outputs that present measles surveillance data from EpiPulse Cases, which are routinely submitted by 30 EU/EEA countries.

ECDC urges EU/EEA public health authorities to focus on the following areas:

  • Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time, as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
  • Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
  • Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
  • Healthcare professionals should be fully vaccinated.
  • Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
  • Address barriers and engage with populations under served by healthcare services. Systemic barriers that impact vaccine uptake in populations which are isolated and under-served by healthcare services need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
  • In light of the upcoming summer holiday season, travellers should check their vaccination status and consult their general practitioner to ensure they are up to date with recommended immunisations prior to departure.


ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.

Latest updates for this event

View all